Mindray And WuXi PharmaTech’s Growth Strategy In 2Q: China Earnings Roundup (Part 1)
This article was originally published in PharmAsia News
Executive Summary
PharmAsia News takes a closer look at how Chinese healthcare companies have fared against the backdrop of a global economic slowdown, starting with two of the country’s leading companies in their respective industries.